|
1 STRATEGIC ANALYSIS OF DOWNSTREAM PROCESSING IN BIOPHARMACEUTICAL PRODUCTION
- Overview
- Research Scope & Methodology
- Research Scope & Methodology
- Introduction & Background
- Introduction & Background
- Market Dynamics
- Market Dynamics
- Industry Challenges
- Key Market Trends
- Key Technology Trends
- Key Market Drivers
- Key Market Restraints
- Future Technology Dynamics
- Future Technology Dynamics
- Key Technology Drivers
- Key Technology Restraints
- Biopharmaceutical Production Costs
- Analysis of Emerging Technologies
- Integrated Solutions
- Major Challenges and Remedial Strategies
- Contract Manufacturing Organisations (CMOs)
- Contract Manufacturing Organisations (CMOs)
- Forecast Assumptions
- CMOs in Downstream Processing
- CMO Market Drivers
- CMO Market Restraints
- Key Market Engineering Measurements
- Total Market Revenue Forecast
- Revenue Analysis
- Competitive Profiles
- CMO Geographic Distribution
- Strategic Analysis & Recommendations
- Strategic Analysis & Recommendations
- Strategic Analysis
- Strategic Anticipation
- Market Maturation Process
- Competitive Framework
- Potential Threats
- Meeting the Challenge
- Meeting the Challenge - Product Pricing Strategy
- Meeting the Challenge - Strategic Postures
- Frost & Sullivan Awards
- Frost & Sullivan Awards
- Frost & Sullivan Awards Description
- Product Innovation Award
- Technology Leadership Award
- Customer Service Innovation Award
- Market Leadership Award
- Product Differentiation Innovation Award
- Decision Support Databases
- Decision Support Databases
- Global Pharmaceutical R&D Expenditure (1999-2006)
- Number of Biotechnology Companies (1999 - 2006)
- Top 10 Global Pharmaceutical Drug Sales (2003)
- Percentage of Pharmaceutical R&D Expenditure (1999-2006)
- Frost & Sullivan
- Healthcare Team
- Our Capabilities
| 
View Cart
